SEC Form 4 · accession 0001209191-15-017451
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael S. Cuffe
Officer — President-Physician Services
Period of report
Feb 19, 2015
Accepted (ET)
Feb 23, 2015 · 8:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 19, 2015 | M | 6,500 | $17.33 | A | 9,343 | D | |
| Common StockF1 | Feb 19, 2015 | S | 6,500 | $69.8137 | D | 2,843 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $17.33 | Feb 19, 2015 | M | 6,500 | D | — | Nov 2, 2021 | Common Stock | 6,500 | 7,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.80 to $69.84, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The option vested at the end of fiscal years 2012 and 2013 based upon the achievement of certain annual EBITDA performance targets.